EU wholesalers concerned about packaging

The European Commission recently released its "pharmaceutical package," which has some anti-counterfeiting proposals that the European Association of Pharmaceutical Full-line Wholesalers (GIRP) finds troubling. While GIRP was pleased with new legislation to prevent some medications from entering into the legal supply chain, it raised concerns about the number of licenses that distributors across the European Union received. Report.

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.